An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A new write-up looked at whether GHK-Cu, a small naturally occurring peptide linked to wound healing, might help with erectile dysfunction (ED) by supporting blood vessels and tissue. The piece reviews existing studies and claims, but it does not present a big new human trial that proves the peptide fixes ED. Instead, it pieces together laboratory and early-stage evidence about how GHK-Cu works on cells and blood vessels. GHK-Cu is a tiny protein fragment that binds copper (the “Cu” part) and shows up naturally in blood and tissues. Scientists have studied it because it seems to speed tissue repair, reduce inflammation, and affect genes involved in rebuilding skin and blood vessels. In plain terms, think of it as a molecular helper that signals the body to heal and remodel tissue; it’s not a hormone or a traditional drug like Viagra. What the evidence actually shows is mostly lab-based and in animals or cell cultures. Studies suggest GHK-Cu can promote blood vessel growth, limit scarring, and improve markers of tissue regeneration. Those effects are promising because erections depend on healthy blood flow and intact penile tissue. But there’s little to no robust data from large human trials testing GHK-Cu specifically for erectile dysfunction. Any reported benefits in humans so far are preliminary, small, or anecdotal, so we can’t say how well it works, how long it lasts, or how it compares to existing ED treatments. Why this matters is straightforward: ED often reflects underlying blood-vessel or tissue problems, so a treatment that supports vascular health and tissue repair could be useful. People who don’t respond to current medications, or who want options that target tissue health rather than just immediate blood flow, might pay attention to this line of research. It’s also of interest to researchers looking for longer-term regenerative approaches rather than temporary fixes. There are important caveats and risks. GHK-Cu is not an approved medication for ED; it may be sold in research or cosmetic products, but its safety and effectiveness for sexual function are not established in well-controlled human trials. Topical or injected forms could have side effects like local irritation, allergic reactions, or unknown systemic effects. People with medical conditions, on medications, or with heart disease should not assume it’s safe and should consult a clinician. Finally, because much of the evidence is preclinical, excitement should be tempered until properly powered human studies confirm benefits and identify risks. Bottom line: GHK-Cu shows biological activity that could theoretically help the blood vessels and tissue involved in erections, but solid human evidence for treating erectile dysfunction is still lacking.
Source: Portal CNJ